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Effect of Cocaine on HIV Infection 
and Inflammasome Gene 
Expression Profile in HIV Infected 
Macrophages
Venkata Subba Rao Atluri, Sudheesh Pilakka-Kanthikeel, Gabriella Garcia, Rahul Dev Jayant, 
Vidya Sagar, Thangavel Samikkannu, Adriana Yndart & Madhavan Nair
We have observed significantly increased HIV infection in HIV infected macrophages in the presence 
of cocaine that could be due to the downregulation of BST2 restriction factor in these cells. In human 
inflammasome PCR array, among different involved in inflammasome formation, in HIV infected 
macrophages in the presence of cocaine, we have observed significant upregulation of NLRP3, 
AIM2 genes and downstream genes IL-1β and PTGS2. Whereas negative regulatory gene MEFV 
was upregulated, CD40LG and PYDC1 were significantly downregulated. Among various NOD like 
receptors, NOD2 was significantly upregulated in both HIV alone and HIV plus cocaine treated cells. 
In the downstream genes, chemokine (C-C motif) ligand 2 (CCL2), CCL7 and IL-6 were significantly up 
regulated in HIV plus cocaine treated macrophages. We have also observed significant ROS production 
(in HIV and/or cocaine treated cells) which is one of the indirect-activators of inflammasomes formation. 
Further, we have observed early apoptosis in HIV alone and HIV plus cocaine treated macrophages 
which may be resultant of inflammasome formation and cspase-1 activation. These results indicate 
that in case of HIV infected macrophages exposed to cocaine, increased ROS production and IL-1β 
transcription serve as an activators for the formation of NLRP3 and AIM2 mediated inflammasomes 
that leads to caspase 1 mediated apoptosis.
Human immunodeficiency virus (HIV) enters the brain shortly after the infection through the infected periph-
eral blood monocytes/macrophages traversing across the blood brain barrier (BBB) resulting in infection 
of microglia, and to lesser extent astrocytes in the brain which is a hallmark of acquired immunodeficiency 
syndrome (AIDS)-related neuroinflammation. These cells produce cytokines, chemokines and viral proteins 
leading to the neuroinflammation, and eventual neuronal damage1,2. The neuronal damage is further exacerbated 
in the presence of drugs of abuse such as cocaine3,4. Understanding the inflammasome activators, pattern and 
other pathogenic mechanisms in HIV infected macrophages in the presence of cocaine will further help in under-
standing the neuropathogenic mechanisms of HIV infection in cocaine abusers.
Innate immunity is the first line of defense discriminating host proteins and foreign bodies (microorgan-
isms), by sensing the signals of “danger”, such as pathogens (pathogen-associated molecular patterns [PAMPs]) 
or host-derived signals of cellular stress. The innate immune system detects viral infection/danger signals largely 
through germline-encoded pattern recognition receptors (PRRs) present either on cell surface or within the 
intracellular compartment. The PRRs include Toll-like receptors (TLRs), the retinoic acid-inducible gene 1 like 
receptors (RLRs), the nucleotide oligomerization domain-like receptors (NLRs, also called NACHT, LRR and 
PYD domain proteins) and cytosolic DNA sensors. In few instances, while viral proteins are the triggers of these 
receptors, viral nucleic acids are the predominant activators. In response to extracellular signals, TLRs induce a 
signaling cascade that leads to cellular activation and production of inflammatory cytokines [Tumor necrosis 
factor (TNF), Interleukin (IL)-6, IL-8 and type 1 interferons]5. In response to danger signals produced into the 
host cell cytosol, Nod-like receptors (NLRs) come into the action and NLR nucleotide-binding oligomerization 
domain containing protein 1 and 2 (NOD1 and 2) induce a signaling cascade, similar to TLRs and results in 
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inflammatory cytokine production6. Recognition of host or microorganism danger signals trigger the forma-
tion of a multiprotein complex called the inflammasome, that contains caspase 17,8 (Fig. 1). Inflammasome oli-
gomerization requires two signals, a priming signal that results in the transcription of interleukin-1 beta (IL-1β) 
and Interleukin 18 (IL-18), and a second signal that promotes indirect activation of the inflammasome such as 
reactive oxygen species (ROS), ion or membrane perturbations, or extracellular adenosine triphosphate (ATP).
In response to various activators, Apoptosis-associated speck-like protein containing a CARD (PYCARD), 
absent in melanoma 2 (AIM2) and members of the NLR family [NLR Family, Pyrin Domain Containing 1 
(NLRP1), NLRP3, and NLR family CARD domain-containing protein 4 (NLRC4)] can self-oligomerize via 
homotypic NACHT domain interactions to high-molecular weight complexes (probably hexamers or heptamers), 
that trigger caspase-1 (inflammatory caspases) auto-activation9,10. Therefore these NLR multimolecular com-
plexes are termed “inflammasomes,” as they control inflammatory caspases. Activated caspase-1 controls the 
maturation and secretion of proinflammatory cytokines such as IL-1β and IL-18, which direct host responses to 
infection and injury. IL-1β participates in the generation of systemic and local responses to infection and injury 
by generating fever, activating lymphocytes and by promoting leukocyte infiltration at sites of infection or injury. 
Whereas, IL-18 induces IFN-γ production and contributes to T-helper 1 (Th1) cell polarization.The exact compo-
sition of an inflammasome depends on the activator (various microbial and endogenous stimuli) which initiates 
inflammasome assembly. So far, four inflammasomes have been identified based on the NLR protein that they 
contain - the NLRP1 (NALP1) inflammasome, the NLRP3 (NALP3) inflammasome, the IPAF (NLRC4) inflam-
masome and the recently identified AIM2 inflammasome (does not contain any NLR protein).
HIV infection of macrophages sets up inflammation at the cell level but through unexpected mechanisms 
and also, cocaine interact to increase the HIV infection levels in macrophages. Therefore, understanding the 
effect of cocaine on HIV infection, inflammasomes and regulated genes expression in HIV infected macrophages 
may provide insights into the development of potential therapeutic targets for HIV-1 associated neurocognitive 
disorders in cocaine abusers. To understand the increased HIV infection levels in cocaine exposed macrophages, 
we have analyzed the expression of HIV restriction factors [apolipoprotein B mRNA-editing enzyme catalytic 
polypeptide-like 3G (APOBEC3G), Bone Marrow Stromal Cell Antigen 2 (BST2) and Tripartite motif-containing 
protein 5 (TRIM5) alpha] in these cells. As production of ROS is one of the activators of inflammasomes forma-
tion, we have also investigated the production of ROS in these macrophages. Further, we have also investigated 
the apoptosis of HIV infected macrophages in combination with cocaine which could be due to the activation of 
these inflammasomes.
Figure 1. Danger signals or bacterial compounds as activators of inflammasomes and NODs. Schematic 
representation is showing different types and the components of inflammasomes and NOD like receptors. 
Courtesy of AdipoGen Life Sciences (www.adipogen.com).
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Materials and Methods
Isolation and culture of peripheral blood mononuclear cells (PBMC). PBMC were isolated from 
the leukopacks (buffy coats) which were commercially obtained from the community blood bank (One Blood, 
Miami, FL, USA). The buffy coat was diluted with phosphate buffer saline (PBS) (Invitrogen, Gaithersburg, MD) 
at room temperature. The diluted buffy coat was overlaid on top of the Ficoll-Histopaque without disturbing 
the interface of the two liquids. Samples were centrifuged at 1,200 g for 20 min. at room temperature with break 
off settings in the centrifuge (acceleration = 1, deceleration = 0). The PBMC layer at the interface was collected 
and cells were washed once with PBS. The pellet was resuspended in ACK lysing buffer for the lysis of red blood 
cells in samples and incubated on ice for 15 min. Cells were washed with PBS and total cell number and cell 
viability were determined by trypan blue exclusion (Sigma, St. Louis, MO) in a hemocytometer counting cham-
ber. PBMC were re-suspended in culture medium containing Roswell Park Memorial Institute (RPMI) 1640 (Life 
Technologies, Gaithersburg, MD), 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (Sigma, 
St. Louis, MO), 2 mM glutamine (Sigma, St. Louis, MO), 100 μg streptomycin (Sigma, St. Louis, MO), 100 U pen-
icillin (Sigma, St. Louis, MO), and 10% fetal bovine serum (Life Technologies, Gaithersburg, MD).
Differentiation of monocytes into monocyte derived macrophages (MDMs). After 2 h of incuba-
tion, non-adherent cells were removed and the T75 flasks containing adherent monocytes were washed with PBS 
twice and cultured in flasks for 7–10 days in the presence of macrophage colony stimulation factor (MCSF) (2 ng/ml; 
Sigma) at a density of 106 cells/ml. Cells were 98% macrophages as judged by morphology.
Monocyte derived macrophages infection with HIV-1 in the presence of cocaine. These adherent 
macrophages were transferred into 6-well culture plates (1 × 106 cells/well) and infected with different amounts 
(0.5–2 MOI) of HIV-1Ba-L (clade B) (NIH AIDS Reagent Program Cat. # 510) for overnight at 37 °C using previ-
ously established protocols with few modifications11,12. After infection, unabsorbed virus was washed away using 
PBS, and cells were cultured for 10 days in the presence or absence of cocaine (1–2 μM) along with MCSF. HIV 
at 0.5 MOI and cocaine at 1 μM concentration were determined to use for all the experiments based on our dose 
response study for cytotoxicity and HIV infectivity.
MTT cell viability assay. The MTT cell viability assay was carried out to confirm the amount of HIV and/or 
cocaine we have used is not toxic as described by Rao et al. with few modifications13. After 10 days of HIV infec-
tion and/or treatment with different concentrations of cocaine (1 μM and 2μM), 6-well plates were given media 
change with one ml medium and 100 μl of 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide 
(MTT) (100 mg MTT/20 ml PBS) was added for each well and incubated at 37 °C for 3 hours. After that, one 
volume of stop mix solution was added and rocked for about 2 hours, centrifuged and the optical density of 
the solubilized formazan was determined spectrophotometrically by measuring the absorbance at 550 nm after 
transferring into the 96 well plate. The optical density of formazan in each well is directly proportional to the cell 
viability and utilized for calculations.
Measurement of HIV infectivity in macrophages in the presence of cocaine. After 10 days of 
HIV infection and/or cocaine treatment, macrophages were harvested and the supernatant was used to measure 
the p24 production using the p24 antigen ELISA kit (ZeptoMetrix Corp. Cat # 0801200). The manufacturer’s 
kit protocol was followed to detect p24 antigen in the HIV infected and HIV plus cocaine treated macrophages.
Western blot assay for HIV restriction factors protein expression. To investigate the mechanism 
behind the increased HIV infection levels observed in macrophages exposed to the cocaine, we have quantified 
the protein expression of different HIV restriction factors in these cells. Protein was isolated from the cell pellets 
of the macrophages treated with HIV and/or cocaine. For SDS-PAGE, similar amounts of control and test group 
cellular protein, typically 40 μg per lane were used. All the protein samples were separated by using Any KD 
Mini-Protean TGX precast Gels (Bio-Rad, Cat # 456–9034). Proteins were transferred to nitrocellulose mem-
branes and membranes were blocked with 5% skimmed milk in TBS-T (20 mM Tris buffer, pH 7.5, 0.5 M NaCl, 
0.1% Tween 20) for 1 hr. at room temperature and incubated at 4 °C overnight in the primary antibody diluted in 
2% skimmed milk in TBS-T. The primary antibodies used were as follows: anti-APOBEC3G antibody (Millipore 
cat # ABE607, 1/5000), anti-TRIM5 alpha antibody (Millipore cat # ABF206, 1/5000), anti- BST2 (bone marrow 
stromal cell antigen 2) antibody (Millipore cat # ABC149, 1/5000). Subsequently, blots were washed in TBS-T 
(4 times, 10 min each) and incubated for 1 hr at room temperature in horseradish peroxidase-goat anti-rabbit 
antibody (Promega, Cat # W401B) diluted 1/2500 in 2% skim milk in TBS-T. After additional washings, protein 
bands were detected by chemiluminiscence using SuperSignal West Pico Luminol/Enhancer (Thermo Scientific, 
Cat # 1856136) and SuperSignal West Pico substrate (Thermo Scientific, Cat # 1856135). Band density was meas-
ured by using ImageJ software.
mRNA extraction and first strand cDNA synthesis. After 10 days of HIV infection and/or co-treatment 
with optimum concentration of cocaine as described above, macrophages were harvested and the pellet was used 
for the mRNA isolation using illustra triplePrep Kit (GE Healthcare Life Sciences, UK; Cat # 28- 9425-44) and 
on-column DNase treatment step was also performed in the procedure. Purity and concentration of the RNA 
was measured by microspot RNA reader (Synergy HT Multi-Mode Microplate Reader from BioTek, US) and 
RNAs with an OD260 nm/OD280 nm absorbance ratio of at least 2.0 were used for PCR array. One microgram 
of RNA from all the control and test groups (cocaine treated, HIV infected and HIV infected in the presence of 
cocaine) was used for the first strand cDNA synthesis using SABiosciences’s RT2 First Strand Kit (Cat. # 330401) 
as described earlier14,15. Genomic DNA elimination step was performed prior to reverse transcription.
www.nature.com/scientificreports/
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Inflammasome PCR array. Monocyte derived macrophages prepared as above were grown in 6 well cul-
ture plates (1 × 106 cells/well). These cells were infected with optimized concentration (0.5 MOI) of HIV-1Ba-L 
for overnight at 37 °C. Unabsorbed virus was washed away using PBS, and cells were cultured for 10 days in 
the presence or absence of optimized concentration of cocaine (1 μM) along with MCSF. mRNA was extracted 
and first strand cDNA was synthesized as described above and these cDNA were used for the inflammasome 
gene expression profile. Inflammasomes profiling in HIV infected and/or cocaine treated macrophages was 
done using 96 well format Human Inflammasomes RT2 Profiler™ PCR Array Kit (SABiosciences, Cat # PAHS-
097ZA) using Stratagene Mx3000p qRT-PCR instrument. The Human Inflammasomes PCR array interrogates 
84 genes involved in the function of inflammasomes, protein complexes involved in innate immunity, as well 
as general NOD-like receptor (NLR) signaling. This kit was chosen because it includes diverse genes encoding 
inflammasome components as well as genes involved in downstream signaling and inhibition of inflammasome 
function. In addition, this array includes other NLR family members, which may potentially form additional 
inflammasomes, and their downstream signaling genes. Table 1 shows the list of inflammasomes, NOD-like 
receptors, pro-inflammatory caspase genes and negative regulating and down-stream regulating genes we have 
investigated. Relative abundance of each mRNA species was assessed using RT2 SYBR Green/ROX PCR Master 
mix (SABiosciences, Cat # 330520) and aliquoted in equal volumes (25 μl) to each well of the real-time PCR 
arrays. The real-time PCR cycling program (as indicated by the manufacturer) was run on a Stratagene Mx3000p 
qRT-PCR thermal cycler. The threshold cycle (Ct) of each gene was determined by using the Stratagene MaxPro 
software. The threshold and baseline were set manually according to the manufacturer’s instructions. Ct data 
were uploaded into the data analysis template on the manufacturer’s website. The relative expression of each gene 
in HIV and/or cocaine treated macrophages was calculated using ΔΔCT method with five housekeeping genes 
and compared with the expression in control cells. Controls are also included on each array for genomic DNA 
contamination, RNA quality, and general PCR performance.
Effect of HIV-1 and/or cocaine on ROS production in macrophages. Reactive oxygen species (ROS) 
production is known as one of the mechanisms responsible for the activation of inflammasomes. Therefore, we 
hypothesize that exposure of HIV infected macrophages to the cocaine increases ROS production that may con-
tribute for the upregulation of inflammasome forming genes expression. ROS production following exposure 
to HIV-1 and/or cocaine in macrophages were detected using dichloro fluorescein diacetate assay (DCF-DA; 
Molecular Probes, Eugene, OR, USA) using the established protocol16 with few modifications. Cells were cul-
tured in 6-well plates (106 cells/well) overnight to allow them to adhere on the surface of the well. The next day, 
cells were treated with optimized concentration of HIV-1 and/or cocaine for 10 days. After 10 days of infection/
treatment, cells (100,000 cells/well) were transferred into the 96 well plates along with its media and incubated 
overnight. Next day, negative control cells were treated with antioxidant, catalase (0.001 mg) for 2 h. Next, cells 
were treated with DCF-DA (100 mM) for 1 h at 37 °C and finally read in a BioTek Synergy HT microplate reader 
(excitation 485 nm and emission 528 nm; BioTek, Winooski, VT, USA). Cells treated with H2O2 for 2 h was con-
sidered as positive control.
Apoptosis measurement. Inflammasome activation induces the production of pro-inflammatory 
cytokines leading to the apoptosis. To see the effect of upregulated inflammasome forming genes and upregulated 
pro-inflammatory genes expression in HIV infected macrophages exposed to the cocaine, we have measured the 
apoptosis in these cells. Monocyte Derived Macrophages were infected with HIV for 10 days in combination with 
cocaine. At the termination of 10 days infection and/or cocaine treatment, cells were washed twice with cold PBS 
and then resuspended in 1X binding buffer at a concentration of 1 × 106 cells/ml. 100 μl from this is added to a 
5 ml FACS tubes, followed by incubation with 5 μl each of Annexin V and 7-aminoactinomycin D (7-AAD) (BD 
Biosciences, FITC Annexin V Apoptosis Detection Kit I, Cat # 556547) for 15 minutes at RT in the dark. After 
Group Genes
1. Inflammasomes
a) NLRP1: CASP1 (ICE), CASP5, NLRP1.
b) NLRP3: CASP1 (ICE), NLRP3, PYCARD (ASC).
c) IPAF: CASP1, NAIP, NLRC4 (IPAF), PYCARD (ASC).
d) AIM2: AIM2, CASP1 (ICE), PYCARD (ASC).
e) Negative Regulation: BCL2, BCL2L1 (BCL-X), CARD18 (ICEBERG), CD40LG (TNFSF5), CTSB, 
HSP90AA1, HSP90AB1, HSP90B1 (TRA1), MEFV, PSTPIP1, PYDC1 (POP1), SUGT1, TNF, TNFSF11, 
TNFSF14, TNFSF4 (OX40L).
f) Downstream Signaling: IFNG, IL12A, IL12B, IL18, IL1B, IL33, IRAK1, IRF1, MYD88, P2RX7, PANX1, 
PTGS2 (COX2), MOK, RIPK2, TIRAP, TXNIP.
2. NOD-Like Receptors
a) Receptors: CIITA, NAIP (BIRC1), NLRC4 (IPAF), NLRC5, NLRP1, NLRP12, NLRP3, NLRP4, NLRP5, 
NLRP6, NLRP9, NLRX1, NOD1 (CARD4), NOD2.
b) Downstream Signaling: BIRC2 (c-IAP2), BIRC3 (c-IAP1), CARD6, CASP8 (FLICE), CCL2 (MCP-1), 
CCL5 (RANTES), CCL7 (MCP-3), CFLAR (CASPER), CHUK (IKKa), CXCL1, CXCL2, FADD, IFNB1, 
IKBKB, IKBKG, IL6, IRF1, IRF2, MAP3K7 (TAK1), MAPK1 (ERK2), MAPK11, MAPK12, MAPK13, 
MAPK3 (ERK1), MAPK8 (JNK1), MAPK9 (JNK2), NFKB1, NFKBIA (I?Ba/MAD3), NFKBIB (TRIP9), 
PEA15, RELA, RIPK2, SUGT1, TAB1 (MAP3K7IP1), TAB2 (MAP3K7IP2), TNF, TRAF6, XIAP.
3. Pro-Inflammatory Caspases CASP1 (ICE), CASP5.
Table 1.  List of Inflammasomes, NOD-like receptors, Pro-inflammatory caspase genes and negative 
regulating and down-stream regulating genes.
www.nature.com/scientificreports/
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incubation, 400 μl of 1X binding buffer is added to each tube, mixed gently and analyzed by FACScalibur within 
1 hr. The untreated cells, which served as control, is used for defining the basal level of apoptotic and dead cells. 
The percentage of cells that have been induced to undergo apoptosis is then determined by subtracting the per-
centage of apoptotic cells in the untreated population from percentage of apoptotic cells in the treated population. 
Results were analyzed by using the Flowjo software and obtained test samples results were manually compensated 
based on single stain control.
Data Analysis. In the expression studies, a gene was considered differentially regulated if the difference was 
≥2 fold in comparison with the control. Experiments were performed in three independent biological exper-
iments with triplicates and the values obtained were averaged. Relative density of the detected protein bands 
in western blots were measured by using the Image J software. All the results were expressed as mean ± s.e.m. 
Statistical analysis of two groups was performed by Student’s t test, while more than two groups were analyzed 
using one way ANOVA followed by Bonferroni’s multiple comparison test. Differences were considered signif-
icant at p ≤ 0.05. Data analysis was performed with the Statistical Program, GraphPad Prism software (La Jolla, 
CA).
Ethics Statement.  Leukopacks (buffy coats) were commercially obtained from the community blood bank 
(One Blood, Miami, FL, USA), for which ethics committee approval is not required.
Results and Discussion
MTT assay and cytotoxicity. Macrophages were infected with HIV in combination with different concentrations 
of cocaine (1 μM and 2 μM) for 10 days. Cytotoxicity was measured by MTT assay and we have not seen any sig-
nificant cytotoxicity in any of the test group (cocaine/HIV alone and in HIV plus cocaine combined treatment) 
macrophages when compared with the control cells (Fig. 2a). Based on these cytotoxicity report, we have used 
1 uM concentration of cocaine in our further experiments.
Increased macrophages HIV-1 infectivity in the presence of cocaine. Macrophages were infected 
with HIV-1 for 10 days in the presence or absence of cocaine. HIV infectivity was measured by quantifying the 
amount of p24 antigen released into the culture supernatant. We have observed significantly increased HIV infec-
tion in the presence of cocaine (p < 0.05) when compared to the HIV alone-infected cells (Fig. 2b). Our results 
are in agreement with the previous reports showing the increased replication of HIV in the monocyte derived 
macrophages exposed to cocaine17. Reports suggest that immunomodulatory functions of cocaine may positively 
contribute to the increased HIV-1 infection and replication18,19. Also, cocaine has been reported to increase the 
expression of co-receptors [C-X-C chemokine receptor type 4 (CXCR4) and C-C chemokine receptor type 5 
(CCR5)] for HIV in mononuclear cells20. In this study, we have analyzed the expression of different HIV restric-
tion factors and their possible role in the increased HIV infectivity in MDMs exposed to cocaine. Further, we have 
analyzed the expression of different inflammasome participating genes and their regulating and down-stream 
signaling genes to explore the mechanisms of HIV pathogenesis in cocaine abusers.
HIV restriction factors expression in macrophages infected with HIV in the presence of 
cocaine. Mammalian cells express a number of diverse, dominantly acting proteins that are widely expressed 
and function in a cell-autonomous manner to suppress HIV replication. These include BST2, TRIM5α, and 
APOBEC3G. To see the effect of cocaine on the expression of these HIV restriction factors in HIV infected mac-
rophages, HIV infected macrophages were treated with cocaine for 10 days and observed for the expression of 
these restriction factors.
BST2 or Tetherin is an interferon (IFN)-inducible transmembrane and glycosylphosphatidylinositol 
(GPI)-anchored protein that restricts the release of HIV from infected cells. Although BST2 can inhibit the release 
of free virion and helps in cell-free infectivity, restriction of the cell-to-cell spread of virus is less effective21,22. The 
HIV-1 protein Vpu antagonizes the tetherin by a protein-protein interaction and this interaction serves to remove 
BST-2 from the plasma membrane23,24. In this study, we have found significant down-regulation of BST2 protein 
in both HIV infected or cocaine alone treated and in combined treatment when compared with the control cells. 
We did not observe significant downregulation of BST2 in combined treatment when compared to the cocaine 
or HIV alone treated cells (Fig. 3a). These results indicate that down-regulation of Tetherin in HIV infected and 
HIV plus cocaine treated MDMs will help in further release of virions from the infected cells and facilitates the 
infection of the healthy neighboring MDMs.
TRIM5α was first identified as the protein responsible for host restriction of HIV-1 in rhesus macaque cells. 
TRIM5α reported to inhibit HIV-1 infection by targeting the viral capsid following entry, and its association with 
viral capsid leads to the premature uncoating or degradation of the viral capsid25–30. We have observed significant 
upregulation of TRIM5α in cocaine/HIV alone treated and in combined treatment when compared to the control 
cells (Fig. 3b). Although we have seen up-regulation of TRIM5α expression in HIV plus cocaine treated cells than 
HIV alone infected cells, statistically it is not significant.
APOBEC3G protein severely restricts the replication of HIV by extensively deaminating cytosine resi-
dues in the viral genome during reverse transcription. This process introduces mutations (cytosine-to-uracil) 
in the –ve strand viral DNA, leading to either the destabilization of reverse transcripts or the production of 
defective viral proteins31–33. Although APOBEC3G is a potent antiviral molecule, HIV-1 can counteract with 
its accessory protein, viral infectivity factor (Vif). In infected cells, Vif forms an ubiquitin ligase complex with 
Cullin5 (CUL5), Elongin B/C (ELOB/C) and Core binding factor β (CBFβ) that ubiquitinates and degrades 
APOBEC3G34–36. In this study, up-regulated TRIM5α (Fig. 3b) and APOBEC3G in HIV or HIV plus cocaine 
treated cells (Fig. 3c) may indicate the cell combat mechanism against the HIV to restrict the increased infection. 
TRIM5α mRNA expression levels were reported to be lower in the PBMCs of HIV-1-infected subjects than in 
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those of uninfected subjects and seroconverters reported to have lower pre-infection levels of TRIM5alpha than 
did non-seroconverters37. Along with these three restriction factors, we have also analyzed the expression of SAM 
domain and HD domain-containing protein 1 (SAMHD1) in these HIV infected macrophages in combination 
with cocaine. But we did not see the detectable levels of SAMHD1 expression in these primary macrophages in 
our experiments.
Increased ROS production in HIV and/or cocaine treated cells. ROS are a group of highly reactive 
free radicals, produced mainly by phagocytic cells such as neutrophils and macrophages38. An increased oxida-
tive stress condition has been repeatedly described in chronically HIV-1-infected patients, based on: elevated 
extracellular and intracellular ROS levels and ROS production is one of the indirect-activators of inflammas-
omes formation. Therefore, to see the effect of cocaine on HIV induced ROS production and thereby inflammas-
ome formation, we have treated the HIV infected macrophages with cocaine and observed for oxidative stress 
by measuring the ROS production. We have observed significantly increased ROS production in HIV infected 
and/or cocaine treated cells when compared to the control cells. But we did not find additive or synergistically 
increased ROS production in HIV+ cocaine treated cells when compared to the HIV/cocaine alone treated cells 
(Fig. 2c). These results indicate that increased ROS production may be one of the factors responsible for the acti-
vation of inflammasomes in HIV and/or cocaine treated macrophages.
Expression of inflammasome forming genes, regulatory genes and down-stream signaling 
genes in macrophages infected with HIV and/or treated with cocaine. Table 2 shows the list of 
Figure 2. (a) MTT Assay. Monocyte derived macrophages were infected with HIV and/or treated with cocaine 
for 10 days and the cell viability was measured using the MTT assay. We have found no significant cytotoxicity 
in the macrophages at the concentration of cocaine or HIV used in the study. (NS-Not Significant). (b) Increased 
HIV infectivity of MDMs in the presence of cocaine. Monocyte derived macrophages were infected with HIV 
in the presence/absence of cocaine for 10 days and the HIV infectivity was measured by measuring the p24 
antigen production in the culture supernatant using the p24 antigen ELISA Kit. We have found significantly 
increased HIV infectivity in macrophages exposed to cocaine than the HIV infected cells alone. (*p ≤ 0.05). (c) 
ROS Assay. Monocyte derived macrophages were infected with HIV and/or treated with cocaine for 10 days and 
oxidative stress was analyzed by ROS assay. We have found significant ROS production in cocaine alone treated, 
HIV only infected and HIV plus cocaine treated macrophages. (*p ≤ 0.05; NS-Not Significant).
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dysregulated inflammasomes, NOD-like receptors, pro-inflammatory caspase genes and negative regulating and 
down-stream regulating genes in HIV and/or cocaine treated macrophages.
Pro-apoptotic gene, caspase 5 (CASP5) was significantly (≥2 fold) down-regulated in cocaine treated mac-
rophages, and it belongs to the IPAF (NLRC4) inflammasomes family. While cocaine reported to induce the 
apoptosis in macrophages39, the effect of Caspase 5 down-regulation in cocaine treated macrophages need to 
be further investigated. In HIV infected macrophages, AIM2 gene expression was significantly up-regulated. 
The inflammasome negative regulatory genes CD40LG (TNFSF5) and PYDC1 (POP1) were significantly 
down-regulated in HIV infected macrophages, indicating the possible AIM2 mediated inflammasome formation 
in the HIV infected macrophages. The AIM2 recognizes cytosolic dsDNA inflammasome, can be activated by 
viral DNA to trigger caspase-1. AIM2 upregulation was reported in chronic hepatitis B patients and its expression 
is correlated with HBV-associated inflammatory activity40. In HIV infected macrophages treated with cocaine, 
NLRP3 and AIM2 genes were significantly up-regulated, whereas inflammasome negative regulatory genes 
CD40LG and PYDC1 genes were significantly down-regulated. Basal expression of pro-form of IL-1β as well 
as the NLRP3 protein is barely detectable. In the presence of virus/bacteria/PAMPS, their transcription is initi-
ated41. The NLRP3 inflammasome acts as an early mediator of inflammation by cleaving proforms of IL-1β and 
IL-18 and releasing the active forms. In this study, we have observed the significant upregulation of NLRP3 and 
the downstream inflammatory factor IL-1β in HIV infected cocaine exposed macrophages. These observations 
suggest the involvement of NLRP3 inflammasome in the onset and development of the neuroinflammation in 
cocaine abusing HIV patients. These results indicate the possible involvement of both NLRP3 and AIM2 medi-
ated inflammasomes in case of HIV plus cocaine treated cells.
Figure 3. Expression of HIV restriction factors in HIV infected MDMs in the presence of cocaine. 
Monocyte derived macrophages were infected with HIV and/or treated with cocaine for 10 days and the protein 
expression of different HIV restriction factors (BST2, TRIM5α and APOBEC3G) was analyzed by western blot 
assay. We have found significant downregulation of BST2 restriction factor in cocaine alone treated, HIV only 
infected and HIV plus cocaine treated macrophages (a). We have also observed significant upregulation of 
TRIM5α (b) and APOBEC3G (c) protein expression in cocaine alone treated, HIV only infected and HIV plus 
cocaine treated macrophages. Figure 3 is the representative figure of three independent biological experiments. 
Relative density of the detected protein band was measured by using the Image J software and the values 
obtained were averaged. (*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; NS-Not Significant).
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Expression of NOD like receptors, regulatory gens and down-stream signaling genes in 
macrophages infected with HIV and/or treated with cocaine. In macrophages exposed to cocaine 
alone, CCL2/Monocyte chemotactic protein 1 (MCP-1) (−2.1 fold), IL6 (−2.51 fold) were the two downstream 
signaling genes significantly down-regulated when compared to the control cells. In case of HIV infected cells, 
NOD2 (+2.79 fold) and the downstream signaling gene CCL7 (+11 fold) were significantly up-regulated. In 
case of HIV infected cells exposed to cocaine, NOD2 (+2.77 fold) and NLRP3 (+2.07 fold) were significantly 
up-regulated and the downstream signaling genes CCL2 (+2.01 fold), CCL7 (+32 fold), IL6 (+9 fold) were also 
significantly upregulated.
In cocaine alone treated cells, we have observed down-regulation of interleukin 6 (IL-6) which acts as both 
pro-inflammatory cytokine as well as an anti-inflammatory myokine. In particular, IL-6 is involved in differentiation 
of B cells, antibody production, activation of T cells, hematopoiesis, pyrogenesis, corticotropin-releasing factor 
(CRF) stimulation, induction of acute phase proteins in the liver, as well as other neuroendocrine changes42,43. 
IL-6 also has significant indirect anti-inflammatory properties44. Cocaine-induced suppression of proinflamma-
tory IL-6 may mediate impaired host defenses to infections45. In case of HIV infected macrophages incubated 
with cocaine, we have observed 9 fold upregulation of IL-6. Few earlier reports also have reported the elevated 
IL-6 production in in vitro infected monocytic lineage46 as well as in HIV infected patient plasma47 cerebrospinal 
fluid samples48. Also, IL-6 alone has been reported to stimulate the HIV-1 replication in macrophages49.
NOD2 [caspase recruitment domain-containing protein 15 (CARD15)] is an intracellular PRR and mac-
rophage specific protein containing two CARD domains, a large nucleotide binding domain and leucine-rich 
repeats50. Activation of NOD2 results in initiation of both innate and acquired immune responses and the enzy-
matic cleavage of pro-IL-1β, which releases the biologically active form of IL-1β51,52. In case of HIV alone infected 
macrophages, we have observed significant upregulation of NOD2 expression than the control cells. Where as in 
case of HIV infected plus cocaine treated cells, we have observed upregulation of both NOD2 and IL-1β expres-
sion, indicating their possible role in apoptosis in these cells.
Monocyte chemoattractant proteins (MCPs), which belong to the beta chemokine family, and especially CCL2 
(MCP1) and its receptor CCR2 have been implicated in the neurological disorders53. Monocyte/macrophages are 
found to be the major source of CCL254 and regulates the migration and infiltration of monocytes, memory T 
lymphocytes, natural killer (NK) cells, dendritic cells into foci of active inflammation55,56. These β-chemokines 
are well known to induce the neuroinflammation57. In this study, in HIV infected MDMs exposed to cocaine (but 
not in HIV only infected cells), we have observed significant up-regulation of CCL2 expression than the control 
cells. Surprisingly in cocaine alone treated cells, we have seen significant down-regulation of CCL2 expression. 
These results indicate the significant CCL2 mediated inflammatory response in the HIV infected cocaine abusers.
Monocyte Chemoattractant Protein 3 (MCP-3), also called CCL7, is produced by macrophages and some 
tumor cell lines. CCL7 is regarded as one of the most pluripotent chemokines, as it can bind and signal via 
multiple CC chemokine receptors, including CCR1, CCR2 and CCR358. CCL2 and CCL7 are predominantly 
associated with the egress of monocytes out of the bone marrow in response to proinflammatory stimuli59. In 
various disorders associated with increased inflammatory infiltrates like demyelinating diseases, simian virus 
induced acquired immune deficiency syndrome encephalitis, lymphocytic choriomeningitis, and MCAO (mid-
dle cerebral artery occlusion), upregulation of CCL7 was reported60. In this study we have observed the highly 
upregulation of CCL7 in HIV alone (11 fold) when compared to the control cells and synergistic upregulation in 
HIV plus cocaine treated cells (32 fold). Therefore our results show that upregulated CCL7 in HIV alone and HIV 
plus cocaine treated macrophages may be highly responsible in inducing the inflammatory response in the brain.
Genes Cocaine HIV HIV+ Cocaine
AIM21d −1.76 2.28 2.48
CASP51a,3 −3.09 1.09 1.64
CCL22b −2.10 1.73 2.01
CCL72b −1.06 11.07 32.00
CD40LG1e −1.41 −3.01 −2.71
IL12A1f 1.71 −2.59 −1.71
IL1B1f −1.31 1.33 4.26
IL18 −1.12 −1.68 −1.73
IL62b −2.51 1.12 9.06
MEFV1e −1.05 1.83 3.36
NLRP31b,2a 1.28 1.31 2.07
NOD22a 1.02 2.79 2.77
PTGS21f 1.08 −1.87 2.00
PYDC11e 1.71 −2.02 −2.48
Table 2.  List of significantly dysregulated Inflammasomes, NOD-like receptors, Pro-inflammatory caspase 
genes and negative regulating and down-stream regulating genes expression fold change in HIV infected 
and/or cocaine treated monocyte derived macrophages.
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Pro-Inflammatory Caspases in macrophages infected with HIV and/or treated with 
cocaine. Little is known about caspase-5, the mechanisms involved in its activation and physiological func-
tions. CASP-5 is a part of the NLRP1 inflammasome complex8 and reported its role in induction of apoptosis61,62. 
Out of the two pro-inflammatory caspases we have analyzed we have only found significant downregulation of 
CASP5 (−3 fold) in cocaine treated macrophages as discussed earlier. In both HIV infected and HIV plus cocaine 
treated cells, we have observed upregulation (<2 fold) of both CASP1 and CASP5 genes. Processing of pro- IL-1β 
into the mature form of IL-1β is mediated by the enzyme CASP1 which is a part of the NLRP1, NLRP3, IPAF and 
AIM2 inflammasome complexes. These results indicate that upregulation of CASP1 and CASP5 genes in HIV or 
HIV plus cocaine treated macrophages induce the activation of the IL-1β that leads to the inflammatory response 
in these conditions.
Apoptosis measurement in HIV infected macrophages in the presence of cocaine. To see the 
effect of changes in inflammasomes and their regulated genes in HIV infected macrophages grown in the pres-
ence of cocaine, we have analyzed the apoptosis levels in these cells. We have observed significant early apoptosis 
in HIV infected and in HIV infected cells in the presence of cocaine when compared to the control cells. We did 
not observe significant early apoptosis in cocaine alone treated macrophages. There is no significantly increased 
early apoptosis levels in HIV plus cocaine treated cells when compared with the HIV alone infected cells. We did 
not see any significant change in the percentage of cells in late apoptosis in any of the test group when compared 
with the control cells (Fig. 4). HIV infected macrophages has been reported to induce apoptosis in bystander 
cells (CD4+ and CD8+ T cells) by releasing soluble cytotoxic factors63,64. Cocaine has been reported to induce 
the apoptosis in HIV infected macrophages by increasing the secretion of cathepsin B39. Role of production of 
different inflammasomes in HIV infected macrophages in the presence of cocaine on apoptosis induction needs 
to be further investigated.
Conclusions
Macrophages are initiators of an inflammatory cascade in HIV infection, which ultimately results in neuronal 
damage and dysfunction65,66; and increased neuroinflammation has been reported in HIV-infected cocaine abus-
ers67. Therefore investigating the mechanisms of HIV infection and inflammatory responses in macrophages 
infected with HIV in combination with cocaine will help us in understanding the neuroinflammatory responses 
in HIV infected cocaine abusers. Our results concur the information on the increased HIV-1 infection levels in 
Figure 4. Apoptosis in HIV infected macrophages grown in the presence/absence of cocaine. Monocyte 
derived macrophages were infected with HIV in the presence/absence of cocaine for 10 days and apoptosis was 
measured by using FITC Annexin V Apoptosis Detection Kit I and the results were analyzed by Flow-cytometer. 
We have observed significant early apoptosis in HIV only infected macrophages (c) as well as in HIV infected 
macrophages grown in the presence of cocaine (d) when compared to the control cells (a). We did not see 
significant apoptosis in cocaine only exposed cells (b) when compared to the control cells. Although there is 
an increase but there is no statistically significantly increased early apoptosis in HIV infected cells grown in the 
presence of cocaine (d) in comparison with the HIV alone infected cells (c). No significant late apoptosis was 
observed in any of the test group cells when compared to the control cells (e). Figure 4 is the representative figure of 
three independent biological experiments and the values obtained were averaged. (**p ≤ 0.01; NS-Not Significant).
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macrophages in the presence of cocaine. Further we have investigated the expression of different HIV restric-
tion factors in HIV infected macrophages treated with cocaine. We have observed significant down-regulation 
of BST2 protein in HIV and HIV plus cocaine treated cells indicating one of the possible mechanism for the 
increased HIV infection in cocaine abusers. In HIV infected macrophages treated with cocaine, we have observed 
significant up-regulation of AIM2, NLRP3 that participate in the formation of inflammasome complexes which 
further induce the caspase-1 pathway and activation of pro-form of IL-1β to active IL-1β which leads to the 
inflammatory response and cell death. Figure 5 shows the schematic representation of effect of HIV infection and 
other activators on inflammasome formation and their cascade that leads to the inflammatory responses and cell 
death in macrophages. In HIV infected macrophages in the presence of cocaine, CCL7 and IL-6 are the highly 
up-regulated genes and persistent high IL-6 production has been implicated in the increased HIV replication, 
development of various autoimmune, chronic inflammatory diseases49,68–70. Down-regulation of inflammasome 
negative regulatory genes CD40LG and PYDC1 in HIV plus cocaine treated cells may also facilitates the forma-
tion of NLRP3 and AIM2 mediated inflammatory response. Further, we have found that in case of HIV infected 
macrophages exposed to cocaine, increased ROS production and subsequent upregulated IL-1β transcription 
may serves as an activators for the formation of NLRP3 and AIM2 mediated inflammasomes that results in 
Caspase 1 activation which may be one of the mechanisms for severe neuroinflmmatory response and apoptosis 
of infected cells in HIV infected cocaine abusers. Further genetic and pharmacological approaches are necessary 
to investigate the inflammsome activators in HIV infected cocaine abusers for better understanding the inflam-
matory/neuroinflammatory response observed in these patients.
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